𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virus

✍ Scribed by Maylin, Sarah; Boyd, Anders; Martinot-Peignoux, Michelle; Delaugerre, Constance; Bagnard, Georges; Lapalus, Martine; Zoulim, Fabien; Lavocat, Fabien; Marcellin, Patrick; Simon, François; Girard, Pierre-Marie; Lacombe, Karine

Book ID
121993536
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
286 KB
Volume
56
Category
Article
ISSN
1386-6532

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship between serum hepatitis B v
Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients
✍ L.Y. Lin; V.W.S. Wong; H.J. Zhou; H.Y. Chan; H.L. Gui; S.M. Guo; H. Wang; L. Hua 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

## Abstract Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is responsible for viral persistence. This study aimed to investigate the serum surrogate markers for cccDNA and to evaluate the intrahepatic viral events associated with disease activity in HBeAg‐negative chronic hepatitis

Long-term outcomes of thymosin-α1 and in
Long-term outcomes of thymosin-α1 and interferon α-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B
✍ Murat Saruc; Nuri Ozden; Nurten Turkel; Semin Ayhan; Lynette M. Hock; Isil Tuzcu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 1 views

Hepatitis B e antibody (HbeAb) and hepatitis B virus (HBV) DNA positive chronic hepatitis is a clinical entity, distinct from classical hepatitis B e antigen (HbeAg) positive chronic hepatitis B. Our aim was to evaluate the long-term therapeutic efficacy of the combination of interferon alpha-2b and